Used as a key intermediate in the synthesis of pharmaceuticals, particularly in the development of active pharmaceutical ingredients (APIs) that require trifluoromethylated aromatic structures. Its bromomethyl group allows for further functionalization through nucleophilic substitution, making it valuable in constructing complex molecules. Commonly employed in medicinal chemistry for creating analogs in drug discovery programs, especially in the design of compounds with enhanced metabolic stability and binding affinity. Also utilized in the preparation of agrochemicals and specialty materials where fluorinated moieties improve performance characteristics.